Document Detail


Otologics middle ear transducer with contralateral conventional hearing aid in severe sensorineural hearing loss: evolution during the first 24 months.
MedLine Citation:
PMID:  20418795     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To report the audiometric outcomes of patients with severe sensorineural hearing loss and who have been fitted with a Middle Ear Transducer (MET) on one side and fitted with an optimized conventional hearing aid on the other side. STUDY DESIGN: The MET fitting results were measured and compared with contralateral conventional hearing aids in a prospective study. SETTING: Tertiary referral center. PATIENTS: Seven patients (ages, 53-77 yr) with severe sensorineural hearing loss (pure-tone average, 71-90 dB HL) were implanted between December 2004 and March 2006. METHOD: Audiometric testing was performed the day of activation (2 mo postoperative) and after 8 days and 1, 3, 6, 9, 12, and 24 months. For each follow-up, MET and conventional hearing aid were optimized according to the patient's hearing loss. RESULTS: Mean functional gains were 29 dB for conventional hearing aid and 35 dB the first day of the study with the MET and 39 dB after 6 months. DISCUSSION: The performance of the MET and the absence of occlusion of the external auditory canal could explain the improved benefit. For maximum gain, the MET requires a regular follow-up during the first 6 months. CONCLUSION: MET seems to be a suitable and successful treatment option resulting in significant improvement in speech comprehension, especially after 6 months, in patients with severe sensorineural hearing loss. During the 24-month follow-up of this study, the MET has been a safe and effective treatment for severe hearing loss.
Authors:
Stéphane Tringali; Xavier Perrot; Paul Berger; Genevieve Lina Granade; Christian Dubreuil; Eric Truy
Related Documents :
8155895 - Communication strategies of adult cochlear implant candidates.
3430375 - Speech discrimination with an 8-channel compression hearing aid and conventional aids i...
8729915 - Noise exposure associated with hearing aid use in industry.
6887805 - Performance characteristics for hearing aid microphone versus telephone and telephone/t...
1192405 - Alcohol and alcohol-related deficiencies as carcinogens.
16762115 - A campaign of "communication for behavioural impact" to improve mass drug administratio...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology     Volume:  31     ISSN:  1537-4505     ISO Abbreviation:  Otol. Neurotol.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-26     Completed Date:  2010-10-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100961504     Medline TA:  Otol Neurotol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  630-6     Citation Subset:  IM    
Affiliation:
Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Otology and Oto-neurosurgery, F-69495 Pierre-Bénite, France. stephane.tringali@chu-lyon.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acoustic Stimulation
Aged
Audiometry
Auditory Threshold
Ear, Middle / surgery*
Female
Hearing Aids*
Hearing Loss, Sensorineural / rehabilitation,  surgery*
Humans
Male
Middle Aged
Ossicular Prosthesis*
Patient Satisfaction
Prospective Studies
Prosthesis Implantation
Questionnaires
Speech Perception
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adenoma of the ceruminous gland (ceruminoma).
Next Document:  Transcanal Endoscopic Management of Cholesteatoma.